Downregulation of cell‐free miR‐198 as a diagnostic biomarker for lung adenocarcinoma‐associated malignant pleural effusion

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Cancer

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.28054PMID 23354517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis.

  2012cited by this paper
• Reference miRNAs for miRNAome Analysis of Urothelial Carcinomas

  2012cited by this paper
• MET signaling: novel targeted inhibition and its clinical development in lung cancer.

  2012cited by this paper
• Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients.

  2012cited by this paper
• Low Levels of Cell-Free Circulating miR-361-3p and miR-625* as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors

  2012cited by this paper
• Circulating microRNAs in cancer: diagnostic and prognostic significance

  2012cited by this paper
• Identification of Suitable Reference Genes for qPCR Analysis of Serum microRNA in Gastric Cancer Patients

  2012cited by this paper
• The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis

  2011cited by this paper
• Extracellular microRNA: a new source of biomarkers.

  2011cited by this paper
• Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• MicroRNAs in body fluids—the mix of hormones and biomarkers

  2011cited by this paper
• Dysregulation of microRNAs in cancer: Playing with fire

  2011cited by this paper
• MicroRNA in lung cancer diagnostics and treatment.

  2011cited by this paper
• Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer

  2011cited by this paper
• Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions.

  2011cited by this paper
• miRNAs in lung cancer: large roles for small players.

  2011cited by this paper
• miR‐198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c‐MET pathway

  2011cited by this paper
• Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma

  2010cited by this paper
• MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.

  2010cited by this paper
• Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions

  2010cited by this paper
• The microRNA spectrum in 12 body fluids.

  2010cited by this paper
• MicroRNAs in cancer - from research to therapy.

  2010cited by this paper
• MiRNAs as biomarkers and therapeutic targets in cancer.

  2010cited by this paper
• Staging of non-small cell lung cancer (NSCLC): a review.

  2010cited by this paper
• Diagnostic value of Her‐2/neu, Cyfra 21‐1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma

  2010cited by this paper
• The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

  2009cited by this paper
• Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?

  2009cited by this paper
• A novel and universal method for microRNA RT-qPCR data normalization

  2009cited by this paper
• Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

  2008cited by this paper
• Management of Malignant Pleural Effusions

  2008cited by this paper
• Expression and mutational analysis of MET in human solid cancers

  2008cited by this paper
• Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21‐1 in patients with pleural effusion: a systematic review and meta‐analysis

  2007cited by this paper
• MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma

  2007cited by this paper
• Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion

  2006cited by this paper
• Biological activity and biotechnological aspects of peptide nucleic acid.

  2006cited by this paper
• Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.

  2005cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004influential reference
• The functions of animal microRNAs

  2004influential reference
• c-Met: Structure, functions and potential for therapeutic inhibition

  2003cited by this paper
• Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.

  2003cited by this paper
• Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.

  2001cited by this paper
• Management of malignant pleural effusions.

  2001cited by this paper
• The diagnostic yield of pleural fluid cytology in malignant pleural effusions.

  2000influential reference
• Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination.

  1991influential reference

• A novel approach in the identification of microRNAs in malignant pleural effusion for lung cancer diagnosis

  2026cites this paper
• Pleural fluid biomarkers for the diagnosis and management of malignant pleural effusions: a clinical review.

  2025cites this paper
• Distribution characteristics of intestinal flora in patients with OSAHS and the relationship between different intestinal flora and sleep disorders, hypoxemia and obesity

  2024cites this paper
• miRNAs in ovarian disorders: Small but strong cast.

  2024cites this paper
• MicroRNA expression in pleural fluid as a diagnostic biomarker of malignant pleural effusion: promise, pragmatism, and the path forward

  2023cites this paper
• Nucleic acids in pleural fluid for the etiological diagnosis of pleural effusion

  2023cites this paper
• Peritoneal Fluid Analysis of Advanced Ovarian Cancers after Hyperthermic Intraperitoneal Chemotherapy

  2023cites this paper
• MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy

  2023cites this paper
• Liquid biopsy: the value of different bodily fluids.

  2022cites this paper
• Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma

  2022cites this paper
• Pleural fluid biochemical analysis: the past, present and future

  2022cites this paper
• Circular RNA Controls Tumor Occurrence and Development via Cell Cycle Regulation

  2022cites this paper
• Diagnostic utility of pleural cell-free nucleic acids in undiagnosed pleural effusions

  2022cites this paper
• The promising role and prognostic value of miR-198 in human diseases.

  2022cites this paper
• ECM Mechanoregulation in Malignant Pleural Mesothelioma

  2022cites this paper
• The Role of miRNA in Ovarian Cancer: an Overview

  2022cites this paper
• Circular RNA circSP3 promotes hepatocellular carcinoma growth by sponging microRNA-198 and upregulating cyclin-dependent kinase 4

  2021cites this paper
• 液体活检在肺癌伴恶性胸腔积液诊疗中的研究进展

  2021cites this paper
• Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions

  2021cites this paper
• High Diagnostic and Prognostic Value of miRNAs Compared with the Carcinoembryonic Antigen as a Traditional Tumor Marker.

  2021cites this paper
• Circulating MicroRNAs in Blood and Other Body Fluids as Biomarkers for Diagnosis, Prognosis, and Therapy Response in Lung Cancer

  2021cites this paper
• Emerging role and function of miR-198 in human health and diseases.

  2021cites this paper
• CircRNAs in lung adenocarcinoma: diagnosis and therapy.

  2021cites this paper
• Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review

  2021influential citation
• Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion

  2021cites this paper
• Ancillary Studies for Serous Fluids

  2020cites this paper
• Recent advances in the construction of DNA nanostructure with signal amplification and ratiometric response for miRNA sensing and imaging

  2020cites this paper
• The International System for Serous Fluid Cytopathology

  2020cites this paper
• Blood-based Biomarkers for Early Diagnosis of Lung Cancer: A Review Article

  2020cites this paper
• Molecular testing on serous effusions

  2020cites this paper
• Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update

  2020cites this paper
• MicroRNAs – novel biomarkers for malignant pleural effusions

  2019cites this paper
• MicroRNA profiling in serous cavity specimens: Diagnostic challenges and new opportunities

  2019cites this paper
• Injured pancreatic β cells enhance the release of miR-375-3p into the extracellular space.

  2019cites this paper
• Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways

  2019influential citation
• Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.

  2019cites this paper
• Current advances in early detection, residual disease monitoring and treatment response in lung cancer: liquid biopsy

  2018cites this paper
• Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma

  2018cites this paper
• A Semi-Supervised Learning Algorithm for Predicting Four Types MiRNA-Disease Associations by Mutual Information in a Heterogeneous Network

  2018cites this paper
• Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion.

  2018cites this paper
• Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer

  2018cites this paper
• Liquid biopsy for lung cancer early detection.

  2018cites this paper
• Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR

  2018cites this paper
• miRNAs and ovarian cancer: An overview

  2018cites this paper
• MicroRNA‐198 inhibition of HGF/c‐MET signaling pathway overcomes resistance to radiotherapy and induces apoptosis in human non–small‐cell lung cancer

  2018cites this paper
• Aberrant expression of hsa_circ_0025036 in lung adenocarcinoma and its potential roles in regulating cell proliferation and apoptosis

  2018cites this paper
• Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion

  2018cites this paper
• Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion

  2018cites this paper
• Serum miR-10a-5p and miR-196a-5p as non-invasive biomarkers in non-small cell lung cancer.

  2018cites this paper
• Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis

  2017cites this paper
• The diagnostic value of parallel detection of cytokeratin 19 fragment-based tumor markers in malignant pleural effusion: a systematic review and metaanalysis

  2017cites this paper
• Integrating liquid biopsies into the management of cancer

  2017cites this paper
• MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact

  2017cites this paper
• Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.

  2016cites this paper
• Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature

  2016cites this paper
• Pre-analytical issues in effusion cytology

  2016cites this paper
• Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study

  2016cites this paper
• Clinical relevance of circulating cell-free microRNAs in ovarian cancer

  2016cites this paper
• Cell‐free microRNAs in blood and other body fluids, as cancer biomarkers

  2016cites this paper
• MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1.

  2016cites this paper
• [Lung cancer and epigenetic modifications].

  2016cites this paper
• Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer

  2016cites this paper
• Review: Cell Dynamics in Malignant Pleural Effusions

  2015cites this paper
• Indwelling pleural catheters

  2015cites this paper
• Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.

  2015cites this paper
• Circulating Blood-Borne microRNAs as Biomarkers in Solid Tumors.

  2015cites this paper
• miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1.

  2015cites this paper
• Current State of Circulating MicroRNAs as Cancer Biomarkers.

  2015cites this paper
• Circulating microRNAs: potential biomarkers for common malignancies.

  2015cites this paper
• Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma

  2015cites this paper
• Screening of potential biomarkers for chemoresistant ovarian carcinoma with miRNA expression profiling data by bioinformatics approach.

  2015cites this paper
• Prognosis-related microRNAs in esophageal cancer

  2014cites this paper
• MicroRNA‐198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1

  2014cites this paper
• MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8

  2014cites this paper
• miRNA Targeted Therapy in Lung Cancer

  2014cites this paper
• Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion

  2014influential citation
• Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion

  2014cites this paper
• MIR-198 IN PANCREATIC CANCER PROGRESSION AND MANAGEMENT By OLORUNSEUN OLATUNJI OGUNWOBI A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE UNIVERSITY OF FLORIDA

  2013cites this paper
• Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities

  2013cites this paper
• Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection

  2013cites this paper
• Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type

  2013cites this paper
• Isocitrate dehydrogenase 1 ( IDH 1 ) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH 1 wild type

  2013cites this paper